Literature DB >> 6822668

Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.

J E Heffner, S A Shoemaker, E M Canham, M Patel, I F McMurtry, H G Morris, J E Repine.   

Abstract

Macrophages, neutrophils, and platelets may play a role in acute edematous lung injury, such as that seen in the adult respiratory distress syndrome (ARDS), but their potential actions and interactions are unclear. Because stimulated human macrophages and neutrophils can release acetyl glyceryl ether phosphorylcholine (AGEPC), a potent platelet activator, we hypothesized that in ARDS, leukocyte release of AGEPC might stimulate platelets to release thromboxane A2 (TXA2), which then produces pulmonary hypertension and lung edema. In support of this premise, we found that pulmonary hypertension and edema occurred in isolated rabbit lungs perfused with human platelets and AGEPC, but not with platelets or AGEPC alone. Infusion of a vasodilator (nitroglycerin) to maintain base-line pulmonary artery pressures in lungs perfused with platelets and AGEPC prevented the development of lung edema suggesting that platelet and AGEPC-induced edema was hydrostatic in nature. Additional experiments suggested that the increased pressure was a result of TXA2 release from platelets stimulated by AGEPC. Specifically, preincubation of platelets with imidazole, a thromboxane synthetase blocker, prior to infusion with AGEPC significantly diminished pulmonary hypertension and prevented lung edema. Furthermore, pretreating lung preparations with 13-azaprostanoic acid, a TXA2 antagonist, before infusion of AGEPC and untreated platelets also reduced the pulmonary hypertension and blocked the lung edema. The role of TXA2 was further suggested when perfusates from lungs infused with platelets and AGEPC developed high levels of TXA2, whereas perfusates from controls did not. These results suggest that platelet aggregation induced by AGEPC may contribute to ARDS by releasing TXA2, which raises microvascular pressure and increases edema formation, especially when an underlying permeability defect is present.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822668      PMCID: PMC436874          DOI: 10.1172/jci110776

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Lung pathology in respiratory distress following shock in the adult.

Authors:  S R Orell
Journal:  Acta Pathol Microbiol Scand A       Date:  1971

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Effects on the pulmonary circulation of suddenly induced intravascular aggregation of blood platelets.

Authors:  G Bo; J Hognestad
Journal:  Acta Physiol Scand       Date:  1972-08

4.  Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits.

Authors:  L Jorgensen; T Hovig; H C Rowsell; J F Mustard
Journal:  Am J Pathol       Date:  1970-11       Impact factor: 4.307

5.  Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.

Authors:  B Arnoux; D Duval; J Benveniste
Journal:  Eur J Clin Invest       Date:  1980-12       Impact factor: 4.686

6.  Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs.

Authors:  R M Tate; K M Vanbenthuysen; D M Shasby; I F McMurtry; J E Repine
Journal:  Am Rev Respir Dis       Date:  1982-11

7.  Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1981-10

8.  Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals.

Authors:  D M Shasby; K M Vanbenthuysen; R M Tate; S S Shasby; I McMurtry; J E Repine
Journal:  Am Rev Respir Dis       Date:  1982-04

9.  Variables associated with radioimmunoassay of prostaglandins in plasma.

Authors:  H G Morris; N A Sherman; F T Shepperdson
Journal:  Prostaglandins       Date:  1981-05

10.  Correlation of lung compliance and quantities of surfactant phospholipids after acute alveolar injury from N-nitroso-N-methylurethane in the dog.

Authors:  S F Ryan; D F Liau; A L Bell; S A Hashim; C R Barrett
Journal:  Am Rev Respir Dis       Date:  1981-02
View more
  22 in total

1.  Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

2.  Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.

Authors:  P J Piper; A G Stewart
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

3.  Platelet-activating factor (Paf) antagonist, WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis.

Authors:  A W Stanton; T Izumi; J W Antoniw; P J Piper
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Effect of synthetic phospholipids on platelet aggregation and serotonin release.

Authors:  U Söling; H Eibl; G A Nagel; C Unger
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

5.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

Authors:  S W Chang; C O Feddersen; P M Henson; N F Voelkel
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.

Authors:  L M McManus; R N Pinckard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

7.  Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Authors:  M G Sirois; W T de Lima; A J de Brum Fernandes; R J Johnson; G E Plante; P Sirois
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.

Authors:  J P Seale; S Nourshargh; P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 10.  Platelets in lung biology.

Authors:  Andrew S Weyrich; Guy A Zimmerman
Journal:  Annu Rev Physiol       Date:  2012-10-01       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.